Cargando…
Evaluation of the effects of olodaterol on exercise endurance in patients with chronic obstructive pulmonary disease: results from two 6-week crossover studies
BACKGROUND: Two replicate, double-blind, placebo-controlled, 6-week crossover studies assessed the effect of the once-daily long-acting β(2)-agonist olodaterol 5 μg and 10 μg on constant work-rate cycle endurance in patients with moderate to very severe chronic obstructive pulmonary disease. METHODS...
Autores principales: | Maltais, François, Kirsten, Anne-Marie, Hamilton, Alan, De Sousa, Dorothy, Voß, Florian, Decramer, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936013/ https://www.ncbi.nlm.nih.gov/pubmed/27383762 http://dx.doi.org/10.1186/s12931-016-0389-5 |
Ejemplares similares
-
Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
por: O'Donnell, Denis E., et al.
Publicado: (2017) -
Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise
endurance during constant work-rate cycling and endurance shuttle walking in
chronic obstructive pulmonary disease
por: Maltais, François, et al.
Publicado: (2018) -
Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
por: Maltais, François, et al.
Publicado: (2019) -
Effects of Tiotropium/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-/Pooled Analyses
por: Maltais, François, et al.
Publicado: (2020) -
Efficacy and safety of the long-acting β(2)-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease
por: Ichinose, Masakazu, et al.
Publicado: (2015)